Vaccines may not return us to normal. Chaos may come instead

The New York Times reports that ongoing COVID-19 vaccine trials are so different that there will be chaos in the spring.

Published: Oct 14, 2020, 7:00 a.m. MDT

This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company. A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot, the company announced Monday, Oct. 12, 2020. Associated Press

The New York Times recently published a piece about the chaos that may begin within the United States and around the world once COVID-19 vaccines became available.

The simple takeaway — the vaccine won’t be an on-off switch to return us to normal.
“It has not yet dawned on hardly anybody the amount of complexity and chaos and confusion that will happen in a few short months,” Dr. Gregory Poland, the director of the Vaccine Research Group at the Mayo Clinic, told The New York Times.

Americans could be vaccinated and back to ‘regular life’ sometime next year, officials say

Multiple COVID-19 vaccine remain in development from companies like Johnson & Johnson, AstraZeneca, Pfizer and more. All of them are undergoing different tests with different participants.

The future may resemble something like this:

Americans may have to choose between several COVID-19 vaccines. Minor differences could be at play.
The Centers for Disease Control and Prevention may offer guidelines for which COVID-19 vaccine to take depending on your age, gender, weight or more (which is hard to do in itself), according to The New York Times.
There could be a vaccine that may require you to still wear a mask.

Looking for comments?

Find comments in their new home! Click the buttons at the top or within the article to view them — or use the button below for quick access.